Preclinical CRO Market Top Trends 2027 | Charles River Laboratories, Laboratory Corporation of America Holdings, Envigo, Pharmaceutical Product Development

Preclinical CRO Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

Rise in number of drug development activities and growing R&D expenditure in the healthcare sector is expected to drive the preclinical CRO market growth over the forthcoming years. The biopharmaceutical and pharmaceutical industry is spending heavily on clinical R&D. High expenditure associated with such activities have encouraged companies to opt for outsourced preclinical services. The need for deduction in cost and improved productivity builds in further interest in choosing outsourcing or contract research organizations, instigating preclinical CRO market development. According to Global Market Insights, Inc., the preclinical CRO market size is expected to exceed USD 7.8 billion by 2027.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2860

Some of the major companies functioning in the preclinical CRO market include Envigo, Laboratory Corporation of America Holdings, Charles River Laboratories, and Pharmaceutical Product Development among others. Industry players are taking part in strategic initiatives like new/innovative product launches, mergers, acquisitions, and business expansion. For instance, in 2018, Charles River Laboratories acquired MPI Research, a non-clinical research organization that provides comprehensive testing services. This strategy enabled the company to expand early-stage contract research offerings for medical device and biopharmaceutical markets.



As per service type, the preclinical CRO industry is classified into DMPK and bioanalysis studies, toxicology testing, and others. The toxicology testing service segment accounted for USD 1.7 billion of the total market revenue. Toxicity studies include testing of toxicity outline of a drug by sensing its effect on functionality or on organ structure. These studies are important in the preclinical phase, as they recognize and portray all the toxicities related to a drug to anticipate unfavorable events. These benefits could boost the adoption of toxicology testing services in preclinical trial phase.

The preclinical CRO segment is bifurcated into government & academic institutes, medical device companies, biopharmaceutical companies, and others based on end-use. The government and academic institutes will show lucrative growth of 5.6% between 2021 to 2027 owing to the growing number of outsourcing research activities to academic institutes.

Request for customization @ https://www.gminsights.com/roc/2860

The Preclinical CRO market of Asia Pacific is expected to grow at a significant pace of 8.6% during the forecast timeframe. Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiac diseases is the reason for high growth rate in the region. Ongoing preclinical trials in oncology and the increased number of investigational compounds will pave the way for the growth of preclinical CRO business size in the coming years. Additionally, growing concerns of the government regarding the efficacy, drug safety along with the preclinical CROs will further augment business landscape.

Partial Chapter of the Table of Content

Chapter 3 Preclinical CRO Industry Insights

3.1 Industry segmentation

3.2 Industry landscape, 2016 - 2027

3.3 Industry impact forces

3.3.1 Growth drivers

3.3.1.1 Increasing R&D expenditure worldwide

3.3.1.2 Growing outsourcing of R&D activities

3.3.1.3 Rising number of drugs in preclinical trails

3.3.2 Industry pitfalls & challenges

3.3.2.1 Stringent regulatory policies

3.4 Growth potential analysis

3.4.1 By service

3.4.2 By end-use

3.5 Porter’s analysis

3.6 Competitive landscape

3.6.1 Company matrix analysis

3.7 PESTEL analysis

Chapter 4 Preclinical CRO Market, By Service

4.1 Key segment trends

4.2 Bioanalysis & DMPK studies

4.2.1 Market size, by region, 2016 - 2027 (USD Million)

4.3 Toxicology testing

4.3.1 Market size, by region, 2016 - 2027 (USD Million)

4.4 Others

4.4.1 Market size, by region, 2016 - 2027 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/preclinical-cro-market

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.